Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between hiv infected and uninfected people?

Journal of Acquired Immune Deficiency Syndromes

Volumn 72, Issue 2, 2016, Pages 206-213

  So Armah, Kaku A ^a   Tate, Janet P ^b,c   Chang, Chung Chou H ^d   Butt, Adeel A ^d,e,f   Gerschenson, Mariana ^g   Gibert, Cynthia L ^d,h   Leaf, David ^i,j   Rimland, David ^d,k   Rodriguez Barradas, Maria C ^l,m   Budoff, Matthew J ⁿ   Samet, Jeffrey H ^a,n,o   Kuller, Lewis H ^p   Deeks, Steven G ^l   Crothers, Kristina ^q   Tracy, Russell P ^r   Crane, Heidi M ^s   Sajadi, Mohammad M ^t,u   Tindle, Hilary A ^v,x   Justice, Amy C ^b,c   Freiberg, Matthew S ^d,v,w  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HAMAD MEDICAL CORPORATION   (Qatar)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF HAWAII   (United States)

^h GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^o BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^p BOSTON MEDICAL CENTER   (United States)

^q UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^r SAN FRANCISCO GENERAL HOSPITAL   (United States)

^s UNIVERSITY OF WASHINGTON   (United States)

^t UNIVERSITY OF VERMONT   (United States)

^u UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^v BALTIMORE VA MEDICAL CENTER   (United States)

^w UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^x VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Coagulation; HIV; Inflammation; Monocyte activation; Mortality

Indexed keywords

CD14 ANTIGEN; D DIMER; INTERLEUKIN 6; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL ACTIVATION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; MORTALITY RATE; PRIORITY JOURNAL; VIREMIA; AGING; ANALYSIS OF VARIANCE; BLOOD; BLOOD CLOTTING DISORDER; COMPLICATION; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; STATISTICAL MODEL; UNITED STATES; VETERAN; VIROLOGY;

ADULT; AGING; ANALYSIS OF VARIANCE; ANTIGENS, CD14; BIOMARKERS; BLOOD COAGULATION DISORDERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INTERLEUKIN-6; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONOCYTES; UNITED STATES; VETERANS;

EID: 84958793900     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000954     Document Type: Article

References (25)

1. Reiner AP, Lange EM, Jenny NS, et al. Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol. 2013;33:158-164.
2. Di Castelnuovo A, de Curtis A, Costanzo S, et al. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013;98:1476-1480.
3. Baune BT, Rothermundt M, Ladwig KH, et al. Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr). 2011;33:209-217.
4. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.
5. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203: 780-790.
6. Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51-59.
7. Zhu H, Napravnik S, Eron JJ, et al. Decreasing excess mortality of HIVinfected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009. J Acquir Immune Defic Syndr. 2013;63:e150-e157.
8. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8 suppl 2): S13-S24.
9. Armah KA, McGinnis K, Baker J, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55:126-136.
10. Armah KA, Quinn EK, Cheng DM, et al. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study. BMC Infect Dis. 2013; 13:399.
11. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The cardiovascular health study. Ann Epidemiol. 1995;5:278-285.
12. Every NR, Fihn SD, Sales AE, et al. Quality enhancement research initiative in ischemic heart disease: a quality initiative from the department of veterans affairs. Queri IHD executive committee. Med Care. 2000;38(6 suppl 1):I49-I59.
13. Park LS, Tate JP, Rodriguez-Barradas MC, et al. Cancer incidence in HIV-infected versus uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. J AIDS Clin Res. 2014;5:1000318.
14. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388-395.
15. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
16. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS. 2009;23:1227-1234.
17. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
18. Justice AC, Modur SP, Tate JP, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62: 149-163.
19. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27:563-572.
20. Butt AA, Xiaoqiang W, Budoff M, et al. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009;49:225-232.
21. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317-1325.
22. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
23. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
24. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593-614.
25. Long JS, Freese J. Regression Models for Categorical Dependent Variables. 3rd ed. College Station, TX: Stata Press; 2014.